APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dasatinib Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dasatinib Drugs Market Analysis and Forecast 2026-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchDasatinib Drugs Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Dasatinib Drugs Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Dasatinib Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dasatinib Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Dasatinib Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Dasatinib Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dasatinib Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dasatinib Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dasatinib Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dasatinib Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dasatinib Drugs include LUCIUS Pharma and Bristol-Myers Squibb etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dasatinib Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dasatinib Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Dasatinib Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dasatinib Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dasatinib Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dasatinib Drugs sales, projected growth trends, production technology, application and end-user industry.

Dasatinib Drugs Segment by Company

LUCIUS Pharma

Bristol-Myers Squibb

Dasatinib Drugs Segment by Type

70mg

50mg

20mg

Dasatinib Drugs Segment by Application

CML

ALL

Dasatinib Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dasatinib Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dasatinib Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dasatinib Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dasatinib Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dasatinib Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dasatinib Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dasatinib Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 70mg Major Manufacturers Table 3. 50mg Major Manufacturers Table 4. 20mg Major Manufacturers Table 5. Global Dasatinib Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. CML Major Manufacturers Table 7. ALL Major Manufacturers Table 8. Dasatinib Drugs Industry Trends Table 9. Dasatinib Drugs Industry Drivers Table 10. Dasatinib Drugs Industry Opportunities and Challenges Table 11. Dasatinib Drugs Industry Restraints Table 12. Global Dasatinib Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Dasatinib Drugs Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Dasatinib Drugs Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Dasatinib Drugs Revenue Market Share by Region (2021-2026) Table 16. Global Dasatinib Drugs Revenue Market Share by Region (2027-2032) Table 17. Global Dasatinib Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Dasatinib Drugs Sales by Region (2021-2026) & (k units) Table 19. Global Dasatinib Drugs Sales by Region (2027-2032) & (k units) Table 20. Global Dasatinib Drugs Sales Market Share by Region (2021-2026) Table 21. Global Dasatinib Drugs Sales Market Share by Region (2027-2032) Table 22. Global Dasatinib Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Dasatinib Drugs Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Dasatinib Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Dasatinib Drugs Sales Market Share by Manufacturers (2021-2026) Table 26. Global Dasatinib Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Dasatinib Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Dasatinib Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Dasatinib Drugs Manufacturers, Product Type & Application Table 30. Global Dasatinib Drugs Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Dasatinib Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Dasatinib Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Dasatinib Drugs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Dasatinib Drugs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Dasatinib Drugs Revenue Market Share by Type (2021-2026) Table 37. Global Dasatinib Drugs Revenue Market Share by Type (2027-2032) Table 38. Global Dasatinib Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Dasatinib Drugs Sales by Type (2021-2026) & (k units) Table 40. Global Dasatinib Drugs Sales by Type (2027-2032) & (k units) Table 41. Global Dasatinib Drugs Sales Market Share by Type (2021-2026) Table 42. Global Dasatinib Drugs Sales Market Share by Type (2027-2032) Table 43. Global Dasatinib Drugs Price by Type (2021-2026) & (US$/unit) Table 44. Global Dasatinib Drugs Price by Type (2027-2032) & (US$/unit) Table 45. Global Dasatinib Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Dasatinib Drugs Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Dasatinib Drugs Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Dasatinib Drugs Revenue Market Share by Application (2021-2026) Table 49. Global Dasatinib Drugs Revenue Market Share by Application (2027-2032) Table 50. Global Dasatinib Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Dasatinib Drugs Sales by Application (2021-2026) & (k units) Table 52. Global Dasatinib Drugs Sales by Application (2027-2032) & (k units) Table 53. Global Dasatinib Drugs Sales Market Share by Application (2021-2026) Table 54. Global Dasatinib Drugs Sales Market Share by Application (2027-2032) Table 55. Global Dasatinib Drugs Price by Application (2021-2026) & (US$/unit) Table 56. Global Dasatinib Drugs Price by Application (2027-2032) & (US$/unit) Table 57. LUCIUS Pharma Company Information Table 58. LUCIUS Pharma Business Overview Table 59. LUCIUS Pharma Dasatinib Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. LUCIUS Pharma Dasatinib Drugs Product Portfolio Table 61. LUCIUS Pharma Recent Development Table 62. Bristol-Myers Squibb Company Information Table 63. Bristol-Myers Squibb Business Overview Table 64. Bristol-Myers Squibb Dasatinib Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Bristol-Myers Squibb Dasatinib Drugs Product Portfolio Table 66. Bristol-Myers Squibb Recent Development Table 67. North America Dasatinib Drugs Revenue by Type (2021-2026) & (US$ Million) Table 68. North America Dasatinib Drugs Revenue by Type (2027-2032) & (US$ Million) Table 69. North America Dasatinib Drugs Sales by Type (2021-2026) & (k units) Table 70. North America Dasatinib Drugs Sales by Type (2027-2032) & (k units) Table 71. North America Dasatinib Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 72. North America Dasatinib Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 73. North America Dasatinib Drugs Revenue by Application (2021-2026) & (US$ Million) Table 74. North America Dasatinib Drugs Revenue by Application (2027-2032) & (US$ Million) Table 75. North America Dasatinib Drugs Sales by Application (2021-2026) & (k units) Table 76. North America Dasatinib Drugs Sales by Application (2027-2032) & (k units) Table 77. North America Dasatinib Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 78. North America Dasatinib Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 79. North America Dasatinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Dasatinib Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 81. North America Dasatinib Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 82. North America Dasatinib Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 83. North America Dasatinib Drugs Sales by Country (2021-2026) & (k units) Table 84. North America Dasatinib Drugs Sales by Country (2027-2032) & (k units) Table 85. North America Dasatinib Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 86. North America Dasatinib Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 87. United States Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 88. Canada Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 89. Mexico Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 90. Europe Dasatinib Drugs Revenue by Type (2021-2026) & (US$ Million) Table 91. Europe Dasatinib Drugs Revenue by Type (2027-2032) & (US$ Million) Table 92. Europe Dasatinib Drugs Sales by Type (2021-2026) & (k units) Table 93. Europe Dasatinib Drugs Sales by Type (2027-2032) & (k units) Table 94. Europe Dasatinib Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 95. Europe Dasatinib Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 96. Europe Dasatinib Drugs Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Dasatinib Drugs Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Dasatinib Drugs Sales by Application (2021-2026) & (k units) Table 99. Europe Dasatinib Drugs Sales by Application (2027-2032) & (k units) Table 100. Europe Dasatinib Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 101. Europe Dasatinib Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 102. Europe Dasatinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Dasatinib Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 104. Europe Dasatinib Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 105. Europe Dasatinib Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 106. Europe Dasatinib Drugs Sales by Country (2021-2026) & (k units) Table 107. Europe Dasatinib Drugs Sales by Country (2027-2032) & (k units) Table 108. Europe Dasatinib Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 109. Europe Dasatinib Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 110. Germany Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 111. France Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 112. U.K. Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 113. Italy Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 114. Russia Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 115. Spain Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 116. Netherlands Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 117. Switzerland Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 118. Sweden Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 119. Poland Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 120. China Dasatinib Drugs Revenue by Type (2021-2026) & (US$ Million) Table 121. China Dasatinib Drugs Revenue by Type (2027-2032) & (US$ Million) Table 122. China Dasatinib Drugs Sales by Type (2021-2026) & (k units) Table 123. China Dasatinib Drugs Sales by Type (2027-2032) & (k units) Table 124. China Dasatinib Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 125. China Dasatinib Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 126. China Dasatinib Drugs Revenue by Application (2021-2026) & (US$ Million) Table 127. China Dasatinib Drugs Revenue by Application (2027-2032) & (US$ Million) Table 128. China Dasatinib Drugs Sales by Application (2021-2026) & (k units) Table 129. China Dasatinib Drugs Sales by Application (2027-2032) & (k units) Table 130. China Dasatinib Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 131. China Dasatinib Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 132. Asia Dasatinib Drugs Revenue by Type (2021-2026) & (US$ Million) Table 133. Asia Dasatinib Drugs Revenue by Type (2027-2032) & (US$ Million) Table 134. Asia Dasatinib Drugs Sales by Type (2021-2026) & (k units) Table 135. Asia Dasatinib Drugs Sales by Type (2027-2032) & (k units) Table 136. Asia Dasatinib Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 137. Asia Dasatinib Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 138. Asia Dasatinib Drugs Revenue by Application (2021-2026) & (US$ Million) Table 139. Asia Dasatinib Drugs Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Dasatinib Drugs Sales by Application (2021-2026) & (k units) Table 141. Asia Dasatinib Drugs Sales by Application (2027-2032) & (k units) Table 142. Asia Dasatinib Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 143. Asia Dasatinib Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 144. Asia Dasatinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Dasatinib Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Asia Dasatinib Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Asia Dasatinib Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 148. Asia Dasatinib Drugs Sales by Country (2021-2026) & (k units) Table 149. Asia Dasatinib Drugs Sales by Country (2027-2032) & (k units) Table 150. Asia Dasatinib Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 151. Asia Dasatinib Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 152. Japan Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 153. South Korea Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 154. India Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 155. Australia Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 156. Taiwan Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 157. Southeast Asia Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 158. SAMEA Dasatinib Drugs Revenue by Type (2021-2026) & (US$ Million) Table 159. SAMEA Dasatinib Drugs Revenue by Type (2027-2032) & (US$ Million) Table 160. SAMEA Dasatinib Drugs Sales by Type (2021-2026) & (k units) Table 161. SAMEA Dasatinib Drugs Sales by Type (2027-2032) & (k units) Table 162. SAMEA Dasatinib Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 163. SAMEA Dasatinib Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 164. SAMEA Dasatinib Drugs Revenue by Application (2021-2026) & (US$ Million) Table 165. SAMEA Dasatinib Drugs Revenue by Application (2027-2032) & (US$ Million) Table 166. SAMEA Dasatinib Drugs Sales by Application (2021-2026) & (k units) Table 167. SAMEA Dasatinib Drugs Sales by Application (2027-2032) & (k units) Table 168. SAMEA Dasatinib Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 169. SAMEA Dasatinib Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 170. SAMEA Dasatinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. SAMEA Dasatinib Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. SAMEA Dasatinib Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. SAMEA Dasatinib Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 174. SAMEA Dasatinib Drugs Sales by Country (2021-2026) & (k units) Table 175. SAMEA Dasatinib Drugs Sales by Country (2027-2032) & (k units) Table 176. SAMEA Dasatinib Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 177. SAMEA Dasatinib Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 178. Brazil Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 179. Argentina Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 180. Chile Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 181. Colombia Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 182. Peru Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 183. Saudi Arabia Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 184. Israel Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 185. UAE Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 186. Turkey Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 187. Iran Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 188. Egypt Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Dasatinib Drugs Distributors List Table 192. Dasatinib Drugs Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Dasatinib Drugs Image Figure 2. Global Dasatinib Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dasatinib Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. 70mg Image Figure 5. 50mg Image Figure 6. 20mg Image Figure 7. Global Dasatinib Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Dasatinib Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. CML Image Figure 10. ALL Image Figure 11. Global Dasatinib Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Dasatinib Drugs Revenue (2021-2032) & (US$ Million) Figure 13. Global Dasatinib Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Dasatinib Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Dasatinib Drugs Revenue Market Share by Region (2021-2032) Figure 16. Global Dasatinib Drugs Sales (2021-2032) & (k units) Figure 17. Global Dasatinib Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Dasatinib Drugs Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Dasatinib Drugs Sales YoY (2021-2032) & (k units) Figure 20. Europe Dasatinib Drugs Sales YoY (2021-2032) & (k units) Figure 21. China Dasatinib Drugs Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Dasatinib Drugs Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Dasatinib Drugs Sales YoY (2021-2032) & (k units) Figure 24. Global Dasatinib Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Dasatinib Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Dasatinib Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Dasatinib Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Dasatinib Drugs Revenue Market Share by Type (2021-2032) Figure 30. Global Dasatinib Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Dasatinib Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Dasatinib Drugs Sales Market Share by Type (2021-2032) Figure 33. Global Dasatinib Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Dasatinib Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Dasatinib Drugs Revenue Market Share by Application (2021-2032) Figure 36. Global Dasatinib Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Dasatinib Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Dasatinib Drugs Sales Market Share by Application (2021-2032) Figure 39. North America Dasatinib Drugs Revenue Share by Type (2021-2032) Figure 40. North America Dasatinib Drugs Sales Share by Type (2021-2032) Figure 41. North America Dasatinib Drugs Revenue Share by Application (2021-2032) Figure 42. North America Dasatinib Drugs Sales Share by Application (2021-2032) Figure 43. North America Dasatinib Drugs Revenue Share by Country (2021-2032) Figure 44. North America Dasatinib Drugs Sales Share by Country (2021-2032) Figure 45. Europe Dasatinib Drugs Revenue Share by Type (2021-2032) Figure 46. Europe Dasatinib Drugs Sales Share by Type (2021-2032) Figure 47. Europe Dasatinib Drugs Revenue Share by Application (2021-2032) Figure 48. Europe Dasatinib Drugs Sales Share by Application (2021-2032) Figure 49. Europe Dasatinib Drugs Revenue Share by Country (2021-2032) Figure 50. Europe Dasatinib Drugs Sales Share by Country (2021-2032) Figure 51. China Dasatinib Drugs Revenue Share by Type (2021-2032) Figure 52. China Dasatinib Drugs Sales Share by Type (2021-2032) Figure 53. China Dasatinib Drugs Revenue Share by Application (2021-2032) Figure 54. China Dasatinib Drugs Sales Share by Application (2021-2032) Figure 55. Asia Dasatinib Drugs Revenue Share by Type (2021-2032) Figure 56. Asia Dasatinib Drugs Sales Share by Type (2021-2032) Figure 57. Asia Dasatinib Drugs Revenue Share by Application (2021-2032) Figure 58. Asia Dasatinib Drugs Sales Share by Application (2021-2032) Figure 59. Asia Dasatinib Drugs Revenue Share by Country (2021-2032) Figure 60. Asia Dasatinib Drugs Sales Share by Country (2021-2032) Figure 61. SAMEA Dasatinib Drugs Revenue Share by Type (2021-2032) Figure 62. SAMEA Dasatinib Drugs Sales Share by Type (2021-2032) Figure 63. SAMEA Dasatinib Drugs Revenue Share by Application (2021-2032) Figure 64. SAMEA Dasatinib Drugs Sales Share by Application (2021-2032) Figure 65. SAMEA Dasatinib Drugs Revenue Share by Country (2021-2032) Figure 66. SAMEA Dasatinib Drugs Sales Share by Country (2021-2032) Figure 67. Dasatinib Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Dasatinib Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 70mg
  • 50mg
  • 20mg
Applications
  • CML
  • ALL
Companies covered
  • LUCIUS Pharma
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dasatinib Drugs Market by Type
  3. 1.2.1 Global Dasatinib Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 70mg
  5. 1.2.3 50mg
  6. 1.2.4 20mg
  7. 1.3 Dasatinib Drugs Market by Application
  8. 1.3.1 Global Dasatinib Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 CML
  10. 1.3.3 ALL
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Dasatinib Drugs Market Dynamics
  1. 2.1 Dasatinib Drugs Industry Trends
  2. 2.2 Dasatinib Drugs Industry Drivers
  3. 2.3 Dasatinib Drugs Industry Opportunities and Challenges
  4. 2.4 Dasatinib Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dasatinib Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dasatinib Drugs Revenue by Region
  3. 3.2.1 Global Dasatinib Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dasatinib Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Dasatinib Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Dasatinib Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dasatinib Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dasatinib Drugs Sales by Region
  9. 3.4.1 Global Dasatinib Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dasatinib Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Dasatinib Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Dasatinib Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dasatinib Drugs Revenue by Manufacturers
  2. 4.1.1 Global Dasatinib Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dasatinib Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dasatinib Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dasatinib Drugs Sales by Manufacturers
  6. 4.2.1 Global Dasatinib Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dasatinib Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dasatinib Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dasatinib Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dasatinib Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dasatinib Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dasatinib Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Dasatinib Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dasatinib Drugs Market CR5 and HHI
  16. 4.8.2 2025 Dasatinib Drugs Tier 1, Tier 2, and Tier 3
5 Dasatinib Drugs Market by Type
  1. 5.1 Global Dasatinib Drugs Revenue by Type
  2. 5.1.1 Global Dasatinib Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dasatinib Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dasatinib Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dasatinib Drugs Sales by Type
  6. 5.2.1 Global Dasatinib Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dasatinib Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Dasatinib Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dasatinib Drugs Price by Type
6 Dasatinib Drugs Market by Application
  1. 6.1 Global Dasatinib Drugs Revenue by Application
  2. 6.1.1 Global Dasatinib Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dasatinib Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dasatinib Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dasatinib Drugs Sales by Application
  6. 6.2.1 Global Dasatinib Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dasatinib Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Dasatinib Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dasatinib Drugs Price by Application
7 Company Profiles
  1. 7.1 LUCIUS Pharma
  2. 7.1.1 LUCIUS Pharma Company Information
  3. 7.1.2 LUCIUS Pharma Business Overview
  4. 7.1.3 LUCIUS Pharma Dasatinib Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 LUCIUS Pharma Dasatinib Drugs Product Portfolio
  6. 7.1.5 LUCIUS Pharma Recent Developments
  7. 7.2 Bristol-Myers Squibb
  8. 7.2.1 Bristol-Myers Squibb Company Information
  9. 7.2.2 Bristol-Myers Squibb Business Overview
  10. 7.2.3 Bristol-Myers Squibb Dasatinib Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bristol-Myers Squibb Dasatinib Drugs Product Portfolio
  12. 7.2.5 Bristol-Myers Squibb Recent Developments
8 North America
  1. 8.1 North America Dasatinib Drugs Market Size by Type
  2. 8.1.1 North America Dasatinib Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Dasatinib Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Dasatinib Drugs Price by Type (2021-2032)
  5. 8.2 North America Dasatinib Drugs Market Size by Application
  6. 8.2.1 North America Dasatinib Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Dasatinib Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Dasatinib Drugs Price by Application (2021-2032)
  9. 8.3 North America Dasatinib Drugs Market Size by Country
  10. 8.3.1 North America Dasatinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dasatinib Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dasatinib Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Dasatinib Drugs Market Size by Type
  2. 9.1.1 Europe Dasatinib Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dasatinib Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Dasatinib Drugs Price by Type (2021-2032)
  5. 9.2 Europe Dasatinib Drugs Market Size by Application
  6. 9.2.1 Europe Dasatinib Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dasatinib Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Dasatinib Drugs Price by Application (2021-2032)
  9. 9.3 Europe Dasatinib Drugs Market Size by Country
  10. 9.3.1 Europe Dasatinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dasatinib Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dasatinib Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Dasatinib Drugs Market Size by Type
  2. 10.1.1 China Dasatinib Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Dasatinib Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Dasatinib Drugs Price by Type (2021-2032)
  5. 10.2 China Dasatinib Drugs Market Size by Application
  6. 10.2.1 China Dasatinib Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Dasatinib Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Dasatinib Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dasatinib Drugs Market Size by Type
  2. 11.1.1 Asia Dasatinib Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dasatinib Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Dasatinib Drugs Price by Type (2021-2032)
  5. 11.2 Asia Dasatinib Drugs Market Size by Application
  6. 11.2.1 Asia Dasatinib Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dasatinib Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Dasatinib Drugs Price by Application (2021-2032)
  9. 11.3 Asia Dasatinib Drugs Market Size by Country
  10. 11.3.1 Asia Dasatinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dasatinib Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dasatinib Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dasatinib Drugs Market Size by Type
  2. 12.1.1 SAMEA Dasatinib Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dasatinib Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dasatinib Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Dasatinib Drugs Market Size by Application
  6. 12.2.1 SAMEA Dasatinib Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dasatinib Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dasatinib Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Dasatinib Drugs Market Size by Country
  10. 12.3.1 SAMEA Dasatinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dasatinib Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dasatinib Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dasatinib Drugs Value Chain Analysis
  2. 13.1.1 Dasatinib Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dasatinib Drugs Production Mode & Process
  6. 13.2 Dasatinib Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dasatinib Drugs Distributors
  9. 13.2.3 Dasatinib Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst